Acute Myeloid Leukemia News and Research

RSS
Acute Myeloid Leukemia (AML) is a rapidly progressing cancer of the blood characterized by the uncontrolled proliferation of immature blast cells in the bone marrow. The Leukemia and Lymphoma Society estimates that over 13,000 new cases of AML were diagnosed and approximately 9,000 deaths from AML occurred in the U.S. during 2007. AML is generally a disease of older adults, and the median age of a patient diagnosed with AML is about 67 years. A majority of elderly patients are not considered candidates for standard induction therapy or decline therapy, resulting in an acute need for new treatment options.
Pediatric acute myeloid leukemia genetic subtypes with poor outcomes show increased inflammatory cytokine signaling

Pediatric acute myeloid leukemia genetic subtypes with poor outcomes show increased inflammatory cytokine signaling

Research findings could bolster the effectiveness of immune-checkpoint therapy

Research findings could bolster the effectiveness of immune-checkpoint therapy

Automated Zebrafish screening for Myeloid Leukemia drug discovery

Automated Zebrafish screening for Myeloid Leukemia drug discovery

New review elucidates current treatment approaches for myelodysplastic syndromes

New review elucidates current treatment approaches for myelodysplastic syndromes

Researchers set sights on a new therapeutic target for aggressive breast cancer

Researchers set sights on a new therapeutic target for aggressive breast cancer

Researchers discover how cancer cells can turn off the immune system to help tumors grow

Researchers discover how cancer cells can turn off the immune system to help tumors grow

St. Baldrick's Scholar grant awarded to CU researcher for investigating new drug to treat infant leukemia

St. Baldrick's Scholar grant awarded to CU researcher for investigating new drug to treat infant leukemia

Researchers discover a new class of more potent and less toxic drugs for leukemia patients

Researchers discover a new class of more potent and less toxic drugs for leukemia patients

Smoking continues to be a leading cause of cancer-related death

Smoking continues to be a leading cause of cancer-related death

Study reveals a specific metabolic adaptation in some patients with acute myeloid leukemia

Study reveals a specific metabolic adaptation in some patients with acute myeloid leukemia

Damon Runyon Cancer Research Foundation names five new Damon Runyon Clinical Investigators

Damon Runyon Cancer Research Foundation names five new Damon Runyon Clinical Investigators

Researchers develop new chemistry on natural compounds to obtain a therapeutic agent for treating leukemia

Researchers develop new chemistry on natural compounds to obtain a therapeutic agent for treating leukemia

Promising results of combination treatment for acute myeloid leukemia to be presented at ASCO 2022

Promising results of combination treatment for acute myeloid leukemia to be presented at ASCO 2022

Three-drug therapy with autologous stem cell transplant improves progression-free survival for multiple myeloma patients

Three-drug therapy with autologous stem cell transplant improves progression-free survival for multiple myeloma patients

Genetically engineered immune cells target cancer cells that may be responsible for leukemia relapse

Genetically engineered immune cells target cancer cells that may be responsible for leukemia relapse

Risk factors for COVID-19 in patients with hematological malignancies

Risk factors for COVID-19 in patients with hematological malignancies

Adolescent and young adult leukemia survivors have reduced long-term survival compared to peers without cancer

Adolescent and young adult leukemia survivors have reduced long-term survival compared to peers without cancer

Researchers make breakthrough in overcoming drug resistance in a rare, devastating blood cancer

Researchers make breakthrough in overcoming drug resistance in a rare, devastating blood cancer

Novel method could bring life-saving benefits of CAR T-cell therapy to patients with acute myeloid leukemia

Novel method could bring life-saving benefits of CAR T-cell therapy to patients with acute myeloid leukemia

Researchers discover a novel signaling pathway that defines interferon responses in blood cancers

Researchers discover a novel signaling pathway that defines interferon responses in blood cancers